Back
New York Times Vs. Cidara Therapeutics Industry Stock Comparison
Buy
70
NYT
New York Times
Last Price:
$54.76
Seasonality Move:
-2.47%
Buy
77
CDTX
Cidara Therapeutics
Last Price:
$52.39
Seasonality Move:
-8.55%
Buy
70
New York Times (NYT)
is a Buy
Is New York Times a Buy, Sell or Hold?
-
The current New York Times [NYT] share price is $56.18. The Score for NYT is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
NYT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $55.32. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NYT Stock Price Chart
What is New York Times's stock price today?
-
The New York Times share price today is $56.18Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NYT is experiencing buying pressure, which is a positive indicator for future bullish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $55.32Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
NYT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 13.86 | Buy |
Relative Strength Index (14 RSI): | 54.93 | Buy |
Chaikin Money Flow: | 601274 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.89 - 56.45) | Buy |
Bollinger Bands (100): | (48.53 - 55.45) | Buy |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.91 | Buy |
Relative Strength Index (14 RSI): | 81.84 | Buy |
Chaikin Money Flow: | 1154906 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.31 - 51.77) | Buy |
Bollinger Bands (100): | (15.88 - 36.04) | Buy |
NYT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.37 | Sell |
20-day SMA: | 55.68 | Buy |
50-day SMA: | 55.2 | Buy |
200-day SMA: | 52.95 | Buy |
8-day EMA: | 40.16 | Buy |
20-day EMA: | 22.11 | Buy |
50-day EMA: | 10.18 | Buy |
200-day EMA: | 2.74 | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.39 | Buy |
20-day SMA: | 42.46 | Buy |
50-day SMA: | 30.72 | Buy |
200-day SMA: | 21.84 | Buy |
8-day EMA: | 50.49 | Buy |
20-day EMA: | 44.06 | Buy |
50-day EMA: | 34.72 | Buy |
200-day EMA: | 23.97 | Buy |
New York Times Earnings Growth & NYT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.06 per share, an increase this year of $0.28 per share, and an increase next year of $0.21 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.
New York Times Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |